Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Infectious Disease
•
General Infectious Disease
Do you recommend procalcitonin to help convince other providers to stop antibiotics in patients with pneumonia in whom a non-infectious diagnosis is strongly suspected?
Related Questions
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
When should antibiotics be discontinued for an immunocompetent patient with signs of meningoencephalitis who undergoes an LP without prior administration of antibiotics and the CSF shows a neutrophilic pleocytosis, negative Gram stain, negative PCR Panel, and negative CSF culture at day 3-5?
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
How would you approach treatment duration for patients with persistent candida species fungemia with a history of a prosthetic heart valve but negative TEE/CT PET and no other identifiable source of infection?
In patients with possible Bartonella henselae infection and elevated IgG titer, what is the best way to confirm the diagnosis: tissue biopsy with Warthin-Starry staining, tissue sent for Bartonella henselae PCR, or tissue sent for culture?
Do you routinely transition from inpatient vancomycin to outpatient daptomycin to decrease the risk of nephrotoxicity and reduce the burden of lab monitoring in a patient with MRSA infection being discharged on home IV antibiotics?
Is there a role for longer courses of antibiotic therapy for infections caused by Actinomyces neuii, similar to courses used for infections caused by other species of Actinomyces, now that it has been reclassified under the genus Winkia?
Do you ever favor cefazolin over ceftriaxone for bacteremia with susceptible E. coli?
How would you manage a patient with Crohn's disease on a biologic and presents with non-bloody diarrhea, normal-appearing mucosa on sigmoidoscopy but severe colitis on biopsy with a positive CMV stain?
Have you incorporated the use of steroids for patients with severe community-acquired pneumonia?
